OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association between lipocalin-2 and mild cognitive impairment or dementia: A systematic review and meta-analysis of population-based evidence
Xiuwen Li, Xiaojie Wang, Lan Guo, et al.
Ageing Research Reviews (2023) Vol. 89, pp. 101984-101984
Closed Access | Times Cited: 8

Showing 8 citing articles:

Multi-omics investigation of prospective therapeutic targets for type 1 diabetes
Yue‐Yang Zhang, Qing Qiao, Bingxue Chen, et al.
Therapeutic Advances in Endocrinology and Metabolism (2025) Vol. 16
Open Access

Increased plasma lipocalin‐2 levels are associated with nonmotor symptoms and neuroimaging features in patients with Parkinson's disease
Yongyan Fan, Xiaohuan Li, Jianjun Ma, et al.
Journal of Neuroscience Research (2024) Vol. 102, Iss. 2
Open Access | Times Cited: 3

Plasmodium knowlesiinfection is associated with elevated circulating biomarkers of brain injury and endothelial activation
Cesc Bertran-Cobo, Elin Dumont, Naqib Rafieqin Noordin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Associations between Microglia and Astrocytic Proteins and Tau Biomarkers across the Continuum of Alzheimer’s Disease
Julia Doroszkiewicz, Agnieszka Kulczynska‐Przybik, Maciej Dulewicz, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7543-7543
Open Access

Lipocalin-2 as a therapeutic target for diabetes neurological complications
Kyoungho Suk
Expert Opinion on Therapeutic Targets (2024), pp. 1-7
Closed Access

Page 1

Scroll to top